MacKeen brings 28 years of imaging expertise in ophthalmic research and pediatric ophthalmic imaging and will drive product initiatives across both Research and Clinical imaging solutions Pleasanton, CA, USA, April 10, 2019 – Today, Phoenix-Micron (Phoenix), a leading provider of advanced ophthalmic imaging solutions for researchers and clinicians, announces Leslie MacKeen has joined the Company
27.03
2019
Phoenix MICRON® CNV System used to test a novel treatment for age-related macular degeneration
In their paper, “Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy,” Askou et al develop an adeno-associated virus (AAV) treatment for age-related macular degeneration. Beautiful fluorescent fundoscopy performed with the Phoenix MICRON® validated the success of the subretinal AAV injection, while precise choroidal neovascularization (CNV) induced by Phoenix laser burns confirmed that the
15.02
2019
Corneal Thickness Analysis using OCT
Corneal images taken with the Phoenix Micron IV OCT used for thickness analysis King et al, a consortium of researchers at a range of institutions, recently used the Phoenix Micron IV OCT to examine corneal thickness in their article, “Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing